Preprint

Article

Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial

This version is not peer-reviewed.

This version is not peer-reviewed.

Downloads

249

Views

298

Comments

0

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

MDPI Initiatives

Important Links

Subscribe

Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.

© 2025 MDPI (Basel, Switzerland) unless otherwise stated

Disclaimer

© 2025 MDPI (Basel, Switzerland) unless otherwise stated